This content is restricted.
Brief
"On Thursday, February 6th, the National Health Surveillance Agency (Anvisa) held a public hearing at its headquarters in Brasília to discuss the public consultations on herbal medicines. The discussions centered around the proposed revisions to the regulatory framework for registering and notifying industrialized herbal products."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested